The ST2 subtype (6% of DLBCL) is consists mostly of GCB DLBCL and is characterized by mutations in TET2, SGK1 and JAK/STAT (SOCS1 and STAT3 mutations), and homing effectors (GNA13 and P2RY8). The gene discussed is TET2; the disease is diffuse large B-cell lymphoma.